Avacta Group (AVCT)


Latest News

Director Deals - Avacta Group PLC (AVCT)

Prof Alastair Smith, Chief Executive Officer, bought 35,800 shares in the company on the 13th March 2018 at a price of 41.9...

Director/PDMR Shareholding

RNS Number: 5787H Avacta Group PLC 13 March 2018 13 March 2018 Avacta Group plc ("Avacta" or "the Group" or "the Company") Director/PDMR Shareholding Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics and research reagents, announces that its Chief Executive Officer, Dr Alastair Smith has today purchased 35,800 ordinary shar...

Price Monitoring Extension

RNS Number: 0323H Avacta Group PLC 07 March 2018 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the execution o...

Summary of Capital Markets Day

RNS Number: 2482E Avacta Group PLC 08 February 2018 8 February 2018 Avacta Group plc ("Avacta" or "the Group" or "the Company") Capital Markets Day Strong Progress and Milestones Outlined to 2021 Avacta Group plc (AIM: AVCT), the developer of Affimer biotherapeutics and reagents, is pleased to provide a review of progress against the objectives set in...

All News

13-03-18Director Deals - Avacta Group PLC (AVCT)StockMarketWire
13-03-18Director/PDMR ShareholdingRNS
07-03-18Price Monitoring ExtensionRNS
08-02-18Summary of Capital Markets DayRNS
02-02-18Six AIM pharma shares on verge of breakthroughInteractive Investor
22-01-18Avacta and OncoSec to CollaborateRNS
18-01-18Result of Annual General MeetingRNS
18-01-18Avacta in line with market forecasts StockMarketWire
18-01-18AGM Business Update and Notice of ResultsRNS
15-01-18HardmanResearch: Affimer Drug Conjugates a realityRNS
15-01-18Avacta agrees development partnership with Glythera StockMarketWire
15-01-18Drug Development Partnership with GlytheraRNS
08-01-18Avacta to host capital markets day StockMarketWire
08-01-18Capital Markets Day NotificationRNS
04-01-18PDMR Dealing and Issue of EquityRNS
03-01-18Avacta CEO to present at Biotech ShowcaseStockMarketWire
03-01-18Presenting at the Biotech Showcase, San FranciscoRNS
18-12-17Issue of EquityRNS
04-12-17Avacta schedules AGMStockMarketWire
04-12-17Posting of Annual Report and Notice of AGMRNS
30-11-17Avacta sets up SIP, issues sharesStockMarketWire
30-11-17Issue of EquityRNS
15-11-17Covance to present Affimer data at forum says AvactaStockMarketWire
15-11-17Covance to Present Affimer Data at ConferenceRNS
14-11-17Holding(s) in CompanyRNS
13-11-17Avacta to present at PEGS EuropeStockMarketWire
13-11-17Avacta to present at PEGS EuropeRNS
13-11-17Avacta to Present at Investor EveningRNS
24-10-17Record Year for Affimers in scientific publications, says Avacta StockMarketWire
24-10-17Affimers in Scientific PublicationsRNS
19-10-17Private Shareholder Update EventRNS
16-10-17Hardman Res.: R&D accelerated to advance assetsRNS
12-10-17Avacta to present at Shares Spotlight EveningStockMarketWire
12-10-17Avacta to Present at Shares Spotlight EveningRNS
10-10-17Avacta to present at the Shares Spotlight Evening in London on 19 October 2017StockMarketWire
10-10-17Avacta CTO to present at US conference StockMarketWire
10-10-17Avacta to Present at Major US ConferenceRNS
09-10-17Director Dealing and Issue of EquityRNS
05-10-17Avacta research collaboration with FIT BiotechStockMarketWire
05-10-17Research collaboration with FIT Biotech OyRNS

RSS feeds

  • Editorial news feed for LSE:AVCT Editorial
  • Regulatory news feed for LSE:AVCT Regulatory